Christopher Jonathan Reynolds, | |
1528 Main St, Parsons, KS 67357-3333 | |
(620) 421-1357 | |
(620) 421-1384 |
Full Name | Christopher Jonathan Reynolds |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1528 Main St, Parsons, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144887704 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-102721 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christopher Jonathan Reynolds, 1528 Main St, Parsons, KS 67357-3333 Ph: (620) 421-1357 | Christopher Jonathan Reynolds, 1528 Main St, Parsons, KS 67357-3333 Ph: (620) 421-1357 |
News Archive
Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.
The Department of Health and Human Services has mailed out a third round of $250 checks to help seniors who enter the Medicare Part D coverage pay gap for prescription drugs, WCAX [in Vermont] reports. "The one-time payment aims to close a gap in coverage for prescription medication. The rebates will go to about 9,000 Vermonters whose out-of-pocket expenses already total more than $940 for the year" (8/11).
Yale University has received a $15 million, five-year U.S. Agency for International Development (USAID) award to advance research utilization in Liberia's health sector.
Ovarian stimulation undertaken by women of advanced maternal age receiving fertility treatment may be disrupting the normal pattern of meiosis - a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm - and leading to abnormalities of chromosome copy numbers that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's syndrome, which is caused by the inheritance of three copies of chromosome 21.
Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.
› Verified 7 days ago
Burl Moore Iii, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3201 N 16th St, Parsons, KS 67357 Phone: 620-421-9200 | |
Dr. Darin Treiber, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1528 Main St, Parsons, KS 67357 Phone: 620-421-1357 | |
Kathy Klosterman, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1528 Main St, Parsons, KS 67357 Phone: 620-421-1357 | |
Kenneth Wesley Mcvey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3201 N 16th St, Parsons, KS 67357 Phone: 620-421-9200 | |
Joel Norris, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1519 Main St, Parsons, KS 67357 Phone: 620-421-4950 | |
Emily Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3201 N 16th St, Pharmacy, Parsons, KS 67357 Phone: 620-421-9200 |